Press Releases

Home > Press Releases

Press Releases (Page 121)

KFSHRC Modernizes Biobank Center… Ushering an Era of Personalized Medicine

RIYADH, Saudia Arabia, Jan. 13, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Center (KFSHRC) has announced the modernization of its Biobank Center, marking a significant milestone in healthcare and medical research within the Kingdom. This modernization aligns with the healthcare goals of Saudi Vision 2030, which emphasize prevention, public health, innovation, and the long-term sustainability of medical... ❯❯❯

Extendicare Announces Timing of 2024 Fourth Quarter Results and Conference Call

MARKHAM, Ontario, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the fourth quarter of 2024 after market close on Thursday, February 27, 2025. A conference call hosted by Michael Guerriere, President and Chief Executive Officer, and David Bacon, Senior Vice President and Chief Financial Officer, will be held on Friday,... ❯❯❯

Exagen Inc. Secures Conditional NY State Approval for New Lupus and Rheumatoid Arthritis Biomarkers and Announces Select Preliminary 2024 Financial Results

New biomarkers on track for commercial launch in January 2025 Preliminary financial results indicate record full-year revenue and AVISE CTD trailing twelve-month ASP, with improvements to adjusted EBITDA and cash burn CARLSBAD, Calif., Jan. 12, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today announced it has received conditional approval from the New York State Department of... ❯❯❯

Galectin Therapeutics to Present at the 2025 MASH-TAG Conference

NORCROSS, Ga., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced that the top-line results of the NAVIGATE trial in patients with MASH cirrhosis and portal hypertension will be presented during the 2025 MASH-TAG Conference, being held January 9-11, 2025 in Park City, Utah. Additionally, Company’s executive leadership will... ❯❯❯

LifeLabs’ President and CEO, Charles Brown, named one of the “Top 50 Healthcare Technology CEOs of 2024”

Toronto, Ontario, Jan. 09, 2025 (GLOBE NEWSWIRE) -- We are pleased to share that LifeLabs’ President and CEO, Charles Brown, has been named one of the “Top 50 Healthcare Technology CEOs of 2024” by The Healthcare Technology Report.   Hundreds of nominations were submitted this year to The Healthcare Technology Report and winners were selected based on leaders’ recent and long-term executive performance over key factors, business... ❯❯❯

KFSHRC’s Study Named Among Top 10 Most Impactful Papers of 2024

RIYADH, Saudia Arabia, Jan. 09, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) has solidified its reputation as a global leader in medical innovation with its study on fully robotic liver transplants recognized as one of the Top 10 Most Impactful Papers of 2024 by the American Society of Transplantation.  Building on KFSHRC’s legacy of breakthroughs, the study, ‘Outcomes of Fully Robotic... ❯❯❯

DiagnaMed Announces Resignation of Director and Grant of Stock Options

TORONTO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF) announces that Elyssia Patterson has resigned from the board. The Company also announces that it has granted an aggregate of 1,000,000 stock options (“Options”) to consultants at a price of $0.05 per common share, expiring five years from the date of grant and vest one-fourth increments with the first batch... ❯❯❯

Sienna Announces Fourth Quarter 2024 Results Release Date and Conference Call

MARKHAM, Ontario, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) announced that it will report its 2024 fourth quarter results after market close on Wednesday, February 19, 2025. Nitin Jain, President and Chief Executive Officer, and David Hung, Chief Financial Officer and Executive Vice President, Investments, will host a conference call for the investment community the following... ❯❯❯

DiagnaMed and QIMC to Advance Hydrogen Production Technology at the Ville Marie Clean Natural Renewable Hydrogen Project

A Strategic collaboration to Accelerate Clean Natural Hydrogen InnovationTORONTO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a leading innovator in hydrogen production technologies and artificial intelligence (AI) applications, is thrilled to announce a strategic collaboration with Québec Innovative Materials Corp. (CSE: QIMC, FSE: 7FJ, OTCQB: QIMCF) (“QIMC”).... ❯❯❯

RadNet, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference January 15th, 2025

LOS ANGELES, Jan. 08, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Dr. Howard Berger, President and Chief Executive Officer, Mark Stolper, Executive Vice President and Chief Financial Officer and Dr. Gregory Sorensen, Executive Vice President... ❯❯❯